Home World News Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or Transplant-Deferred... World News Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or Transplant-Deferred Newly Diagnosed Multiple Myeloma By Ogkologos - March 3, 2025 860 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CEPHEUS study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Getting Help for Sexual Health Problems When You Have Head and... April 14, 2022 As Rates of Some Cancers Increase in Younger People, Researchers Search... May 14, 2025 The art of practicing sustainable science April 22, 2021 Grief Anniversaries January 28, 2022 Load more HOT NEWS Different Microbiota–Host Relationships Relevant to Distinct Immune Checkpoint Blockade Regimens Patient Guide in Prostate Cancer Now Available in Vietnamese Single-Fraction SABR Preferred from Resource and Patient Perspectives for Pulmonary Oligometastases Having a Heart Attack May Make Breast Cancer Grow Faster
